Indivior Pharmaceuticals, Inc.INDV
What Indivior Pharmaceuticals, Inc. does.
Indivior Pharmaceuticals, Inc. and its subsidiaries (together, "Indivior" or the "Company") is the market leader in long-acting injectable medications for opioid use disorder (OUD). Indivior is focused on delivering evidence-based pharmacotherapies for OUD and is committed to advancing the neurobiological understanding of OUD as a chronic, relapsing, but treatable brain disease. For more than 25 years, Indivior has led innovation in addiction medicine, developing differentiated therapeutic solutions that support long-term patient recovery, expand access to care, and drive sustainable value for patients, healthcare systems and stockholders.
Headquartered in the U.S. in Richmond, Virginia, Indivior and its portfolio of products is available primarily in the U.S. with additional products available in Canada, Australia, France, and Germany.
both of which are treatments for OUD. Product availability varies across the countries in which Indivior treatments are available, including in terms of dosage, strength and indication. Our core geographic market (based on the country where the sale originates) is the U.S., which accounted for 85%, 85%, and 83% of net revenues for the years ended December 31, 2025, 2024, and 2023, respectively. In the U.S., we sell only SUBLOCADE and SUBOXONE Film.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | — | $791.0M | $901.0M | $1.1B | $1.2B | $1.2B |
| Net income | — | $205.0M | -$42.0M | -$126.0M | $7.0M | $210.0M |
| Free cash flow | — | $349.0M | -$9.0M | -$308.0M | $7.0M | -$93.0M |
More on INDV.
- Indivior Pharmaceuticals, Inc. summary
- Indivior Pharmaceuticals, Inc. financial statements
- Indivior Pharmaceuticals, Inc. key metrics
- Indivior Pharmaceuticals, Inc. health scores and style box
- Indivior Pharmaceuticals, Inc. earnings
- Indivior Pharmaceuticals, Inc. dividends
- Indivior Pharmaceuticals, Inc. valuation
- Indivior Pharmaceuticals, Inc. ownership and insiders
- Indivior Pharmaceuticals, Inc. peers
Figures from Indivior Pharmaceuticals, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.